Arbutus Biopharma Corporation ABUS Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Arbutus Biopharma Corporation’s reported figures.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's enterprise value?
- Arbutus Biopharma Corporation (ABUS) reported enterprise value of $856.58M in Q1 2026.
- How has Arbutus Biopharma Corporation's enterprise value changed year-over-year?
- Arbutus Biopharma Corporation's enterprise value increased by 35.5% year-over-year, from $632.38M to $856.58M.
- What is the long-term trend for Arbutus Biopharma Corporation's enterprise value?
- Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's enterprise value has grown at a 16.1% compound annual growth rate (CAGR), from $430.94M to $907.82M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.